Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

Steven M. Opal, John P. Pribble, Luis Jáuregui et al.|Critical Care Medicine|2004

Cited by 145